Catalyst Wire Dossier Catalyst Wire Dossier

MSP3-LSP malaria vaccine

MSP3-LSP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSP3-LSP malaria vaccine, covering 2008-05-07 to 2008-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine [Phase 2]

See pricing